Background
The global rise in drug-resistant
Mycobacterium tuberculosis
(
M.tb
), and especially the significant prevalence of isoniazid (INH)-resistance constitute a significant challenge to global health. Therefore, the present study aimed to investigate mutations in prevalent gene loci—involved in INH-resistance phenotype—among
M.tb
clinical isolates from southwestern Iran.
Methods
Drug susceptibility testing (DST) was performed using the conventional proportional method on confirmed 6620
M.tb
clinical isolates, and in total, 15 INH-resistant and 18 INH-susceptible isolates were included in the study. Fragments of six genetic loci most related to INH-resistance (
katG
,
inhA
promoter,
furA
,
kasA
,
ndh
,
oxyR-ahpC
intergenic region) were PCR-amplified and sequenced. Mutations were explored by pairwise alignment with the
M.tb
H37Rv genome.
Results
The analysis of gene loci revealed 13 distinct mutations in INH-resistant isolates. 60% (n = 9) of the INH-resistant isolates had mutations in
katG
, with codon 315 predominately (53.3%, n = 8). Mutation at
InhA
− 15 was found in 20% (n = 3) of resistant isolates. 26.7% (n = 4) of the INH-resistant isolates had
kasA
mutations, of which G269S substitution was the most common (20%, n = 3). The percentage of mutations in
furA
,
oxyR-ahpC
and
ndh
was 6.7% (n = 1), 46.7% (n = 7), and 20% (n = 3), respectively. Of the mutations detected in
ndh
and
oxyR-ahpC
, 5 were also observed in INH-susceptible isolates. This study revealed seven novel mutations, four of which were exclusively in resistant isolates.
Conclusions
This study supports the usefulness of
katG
and
inhA
mutations as a predictive molecular marker for INH resistance. Co-detection of
katG
S315 and
inhA
-15 mutations identified 73.3% (11 out of 15 isolates) of INH-resistant isolates.